Bayer, Blackford Analysis to Work on Medical-Imaging Platform
01 Dicembre 2020 - 04:28PM
Dow Jones News
By Cecilia Butini
Bayer AG said Tuesday that it has entered into a
development-and-license agreement with U.K.-based company Blackford
Analysis Ltd. to build a digital platform for medical imaging.
Under the agreement, Bayer will create artificial
intelligence-enabled solutions to power the platform, which should
allow health-care professionals to manage digital-clinical imaging.
The platform will provide access to diagnostic imaging analysis
applications, protocol management tools and AI algorithms, giving
physicians the potential to increase efficiency and reduce errors,
the German chemical and pharmaceutical conglomerate said.
Blackford Analysis will provide the underlying technology for
Bayer to develop its digital solutions, it added.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
December 01, 2020 10:13 ET (15:13 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Grafico Azioni Bayer (TG:BAYN)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Bayer (TG:BAYN)
Storico
Da Mar 2023 a Mar 2024